http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0255141-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-157
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D281-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60
filingDate 1987-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1992-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1992-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0255141-B1
titleOfInvention Combination of active agents comprising diltiazem and acetylsalicylic acid, their preparation as well as their use in the preparation of medicaments with a thrombocyte-aggregation inhibitory activity
abstract The present invention provides combination of materials for strengthening the antithrombotic action of acetylsalicylic acid. It covers a composition which contains diltiazem or a pharmaceutically acceptable acid-addition salt thereof in combination with acetylsalicylic acid. It also forms the new compound diltiazem acetysalicylate. It also covers compositions containing the above and methods for using the compositions or compound.
priorityDate 1986-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420886
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136460
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129349967
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25273605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407848
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67913328
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395919
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID838
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128108066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395920
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67913329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID39186
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15764027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413434
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229820932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127822818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5816
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10899264
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235090102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235090104
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413220

Total number of triples: 45.